Advertisement
Screener

Genprex, Inc. (GNPX) Investing Cash Flow

1.4 / 5 stars · 9/33 Roast Me

Genprex, Inc. Investing Cash Flow

Genprex, Inc. (GNPX) reported Investing Cash Flow of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-30

  • Genprex, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
  • Genprex, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
  • Genprex, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • Genprex, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $0.00.
  • Genprex, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • Genprex, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $774.64K.
  • Genprex, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$71.21K.
  • Genprex, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$59.73K.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 3 month as first filedNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 6 month as first filedNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 9 month as first filedNet Cash Provided by (Used in) Investing Activities 12 monthNet Cash Provided by (Used in) Investing Activities 12 month as first filed
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$0.00
derived: sum of 2 quarters · filed 2026-03-30
$0.00
derived: sum of 3 quarters · filed 2026-03-30
$0.00
10-K · filed 2026-03-30
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$0.00
derived: sum of 2 quarters · filed 2025-11-14
$0.00
10-Q · filed 2025-11-14
-$1.00
derived: sum of 4 quarters · filed 2026-03-30
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$0.00
10-Q · filed 2025-08-14
-$1.00
derived: sum of 3 quarters · filed 2026-03-30
-$1.00
derived: sum of 4 quarters · filed 2026-03-30
2025-03-31$0.00
10-Q · filed 2025-05-12
-$1.00
derived: sum of 2 quarters · filed 2026-03-30
-$1.00
derived: sum of 3 quarters · filed 2026-03-30
$790.47K
derived: sum of 4 quarters · filed 2026-03-30
2024-12-31-$1.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
-$1.00
derived: sum of 2 quarters · filed 2026-03-30
$790.47K
derived: sum of 3 quarters · filed 2026-03-30
$774.64K
10-K · filed 2026-03-30
$1.17K
10-K · filed 2025-04-01
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$790.47K
derived: sum of 2 quarters · filed 2025-11-14
$774.64K
10-Q · filed 2025-11-14
$1.17K
10-Q · filed 2024-11-13
$764.81K
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$790.47K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$774.64K
10-Q · filed 2025-08-14
$1.17K
10-Q · filed 2024-08-09
$764.81K
derived: sum of 3 quarters · filed 2025-08-14
$743.06K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$15.82K
10-Q · filed 2025-05-12
-$25.65K
derived: sum of 2 quarters · filed 2025-05-12
-$47.41K
derived: sum of 3 quarters · filed 2025-05-12
-$67.41K
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31-$9.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01
-$31.59K
derived: sum of 2 quarters · filed 2025-04-01
-$51.59K
derived: sum of 3 quarters · filed 2025-04-01
-$71.21K
10-K · filed 2025-04-01
2023-09-30-$21.76K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$41.76K
derived: sum of 2 quarters · filed 2024-11-13
-$61.38K
10-Q · filed 2024-11-13
-$81.38K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$20.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$39.63K
10-Q · filed 2024-08-09
-$59.63K
derived: sum of 3 quarters · filed 2024-08-09
-$75.67K
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31-$19.63K
10-Q · filed 2024-05-15
-$39.63K
derived: sum of 2 quarters · filed 2024-05-15
-$55.67K
derived: sum of 3 quarters · filed 2024-05-15
-$77.52K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$36.05K
derived: sum of 2 quarters · filed 2024-04-01
-$57.89K
derived: sum of 3 quarters · filed 2024-04-01
-$59.73K
10-K · filed 2024-04-01
$97.73K
10-K · filed 2023-03-31
2022-09-30-$16.05K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$37.90K
derived: sum of 2 quarters · filed 2023-11-14
-$39.74K
10-Q · filed 2023-11-14
$78.05K
10-Q · filed 2022-11-14
-$213.31K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$21.85K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21
-$23.69K
10-Q · filed 2023-08-21
$45.80K
10-Q · filed 2022-08-12
-$197.27K
derived: sum of 3 quarters · filed 2023-08-21
-$28.98K
derived: sum of 4 quarters · filed 2023-08-21
2022-03-31-$1.84K
10-Q · filed 2023-05-22
$10.32K
10-Q · filed 2022-05-13
-$175.42K
derived: sum of 2 quarters · filed 2023-05-22
-$7.13K
derived: sum of 3 quarters · filed 2023-05-22
$24.39K
derived: sum of 4 quarters · filed 2023-05-22
2021-12-31-$173.58K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$5.29K
derived: sum of 2 quarters · filed 2023-03-31
$26.23K
derived: sum of 3 quarters · filed 2023-03-31
-$83.80K
10-K · filed 2023-03-31
2021-09-30$168.29K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$199.81K
derived: sum of 2 quarters · filed 2022-11-14
$89.78K
10-Q · filed 2022-11-14
-$2.25M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$31.52K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$78.50K
10-Q · filed 2022-08-12
-$2.42M
derived: sum of 3 quarters · filed 2022-08-12
-$2.27M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31-$110.03K
10-Q · filed 2022-05-13
-$2.45M
derived: sum of 2 quarters · filed 2022-05-13
-$2.30M
derived: sum of 3 quarters · filed 2022-05-13
-$2.31M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$2.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$2.19M
derived: sum of 2 quarters · filed 2022-03-30
-$2.20M
derived: sum of 3 quarters · filed 2022-03-30
-$2.34M
10-K · filed 2022-03-30
2020-09-30$152.72K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$141.43K
derived: sum of 2 quarters · filed 2021-11-15
$4.42K
10-Q · filed 2021-11-15
-$87.35K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$11.29K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
-$148.30K
10-Q · filed 2021-08-13
-$240.07K
derived: sum of 3 quarters · filed 2021-08-13
-$198.41K
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31-$137.01K
10-Q · filed 2021-05-17
-$228.78K
derived: sum of 2 quarters · filed 2021-05-17
-$187.12K
derived: sum of 3 quarters · filed 2021-05-17
-$1.07M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$91.77K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26
-$50.11K
derived: sum of 2 quarters · filed 2021-03-26
-$933.57K
derived: sum of 3 quarters · filed 2021-03-26
-$946.90K
10-K · filed 2021-03-26
2019-09-30$41.66K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
-$841.80K
derived: sum of 2 quarters · filed 2020-11-12
-$855.13K
10-Q · filed 2020-11-12
-$919.02K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$883.46K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
-$896.79K
10-Q · filed 2020-08-11
-$960.67K
derived: sum of 3 quarters · filed 2020-08-11
-$967.01K
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31-$13.33K
10-Q · filed 2020-05-14
-$77.22K
derived: sum of 2 quarters · filed 2020-05-14
-$83.56K
derived: sum of 3 quarters · filed 2020-05-14
-$106.20K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$63.89K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$70.22K
derived: sum of 2 quarters · filed 2020-03-30
-$92.86K
derived: sum of 3 quarters · filed 2020-03-30
-$103.32K
10-K · filed 2020-03-30
2018-09-30-$6.34K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$28.98K
derived: sum of 2 quarters · filed 2019-11-14
-$39.43K
10-Q · filed 2019-11-14
-$40.51K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$22.64K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-13
-$33.09K
10-Q · filed 2019-08-13
-$34.17K
derived: sum of 3 quarters · filed 2019-08-13
-$54.28K
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31-$10.45K
10-Q/A · filed 2019-05-20
-$11.53K
derived: sum of 2 quarters · filed 2019-05-20
-$31.64K
derived: sum of 3 quarters · filed 2019-05-20
-$50.90K
derived: sum of 4 quarters · filed 2019-05-20
2017-12-31-$1.08K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$21.19K
derived: sum of 2 quarters · filed 2019-04-01
-$40.44K
derived: sum of 3 quarters · filed 2019-04-01
-$63.42K
10-K · filed 2019-04-01
2017-09-30-$20.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$39.36K
derived: sum of 2 quarters · filed 2018-11-14
-$62.34K
10-Q · filed 2018-11-14
-$79.99K
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$19.25K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
-$42.23K
10-Q · filed 2018-08-14
-$59.88K
derived: sum of 3 quarters · filed 2018-08-14
2017-03-31-$22.98K
10-Q · filed 2018-05-15
-$40.63K
derived: sum of 2 quarters · filed 2018-05-15
2016-12-31-$17.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17
-$89.53K
10-K · filed 2018-04-17
2016-09-30-$71.89K
10-Q · filed 2017-12-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02